Allergies & Asthma

Traffic-related air pollution was responsible for nearly 2 million new asthma cases in children across the globe in 2019, according to a new study. Of the 1.85 million new pediatric asthma cases that were attributed to nitrogen dioxide (NO2), two-thirds occurred in urban areas, reported Susan Anenberg, PhD, of George Washington University in Washington, D.C.,
0 Comments
Traveling can bring excitement, anxiety, and stress, whether you’re driving a short distance for the day or flying across the country for an extended business trip or vacation. Add food allergies to the mix and traveling can be overwhelming. Researching dining and flight options, communicating your allergies with others, remembering to pack important allergy-friendly items,
0 Comments
The Asthma and Allergy Foundation of America is sharing this press release from Amgen to bring you the latest research news. [PRESS RELEASE] First and Only Biologic to Consistently and Significantly Reduce Exacerbations in a Broad Population of Severe Asthma Patients Only Biologic for Severe Asthma Approved With no Phenotype or Biomarker Limitations THOUSAND OAKS,
0 Comments
When you hear “environmental allergies,” trees, grasses, and weeds might be the first allergens that come to mind. Just when you breathe a sigh of relief from waning outdoor allergens, prepare for sneaky indoor environmental allergens. Mold and dust mites trigger allergies throughout the year. But, as winter rolls around and you begin spending more
0 Comments
The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenance treatment for patients ages 12 and older with severe asthma. It is not intended for acute bronchospasm or status asthmaticus. As a first-in-class
0 Comments
Interventions to de-escalate use of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) are necessary and beneficial, researchers said during the federal posters session at the American Society of Health-System Pharmacists (ASHP) Midyear virtual meeting. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend long-acting beta2-agonists (LABA) and long-acting muscarinic
0 Comments
NEW ORLEANS — Although still technically an orphan disease, hereditary angioedema (HAE) remains a popular focus for drug developers despite a half-dozen products already approved in the U.S. That was on full display at the American College of Allergy, Asthma and Immunology’s annual meeting here, with phase II studies on two investigational agents featured in
0 Comments
NEW ORLEANS — Everyone who received their second dose of the Moderna or Pfizer mRNA vaccine against COVID-19 at military facilities after experiencing allergic reactions to the first did just fine without any pretreatment, a physician reported here. These individuals were observed closely, of course, and some underwent allergy testing beforehand to ascertain whether they
0 Comments
Renegade’s SWEAT-X Free and Clear Laundry Detergent removes pet and dust mite allergens with fragrance-free formula. The Asthma and Allergy Foundation of America (AAFA) and Allergy Standards Limited (ASL) has announced that Renegade’s SWEAT-X Free and Clear is the first laundry detergent to earn the asthma & allergy friendly® certification. When used to wash bedding
0 Comments